These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 8188080
21. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival. Ofner D, Bier B, Heinrichs S, Berghorn M, Dünser M, Hagemann HA, Langer D, Böcker W, Schmid KW. Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325 [Abstract] [Full Text] [Related]
22. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Derenzini M, Sirri V, Trerè D, Ochs RL. Lab Invest; 1995 Oct; 73(4):497-502. PubMed ID: 7474921 [Abstract] [Full Text] [Related]
23. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. Giri DD, Nottingham JF, Lawry J, Dundas SA, Underwood JC. J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879 [Abstract] [Full Text] [Related]
24. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. Crocker J, Macartney JC, Smith PJ. J Pathol; 1988 Feb; 154(2):151-6. PubMed ID: 3280766 [Abstract] [Full Text] [Related]
25. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa. Piffkò J, Bànkfalvi A, Ofner D, Rasch D, Joos U, Schmid KW. Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314 [Abstract] [Full Text] [Related]
26. Quantitative analysis of three-dimensional distribution of AgNOR proteins during interphase in leukemic cells. Wozniak ZM, Usson Y, Parazza F, Champelovier P, Leroux D, Seigneurin D. Cytometry; 1996 May 01; 24(1):14-26. PubMed ID: 8723898 [Abstract] [Full Text] [Related]
27. Standardized AgNOR analysis as a prognostic parameter in endometrial carcinoma, endometrioid type. Giuffrè G, Fulcheri E, Gualco M, Fedele F, Tuccari G. Anal Quant Cytol Histol; 2001 Feb 01; 23(1):31-9. PubMed ID: 11233741 [Abstract] [Full Text] [Related]
28. Expression of silver-stained nucleolar organizer regions is coupled to cell cycle in rat thymic cells. Carbajo S, Orfao A, Vicente-Villardón JL, Carbajo-Pérez E. Cytometry; 1993 Feb 01; 14(1):46-52. PubMed ID: 8432202 [Abstract] [Full Text] [Related]
29. Histologic characterization of uterine papillary serous adenocarcinoma. Miller B, Umpierre S, Tornos C, Burke T. Gynecol Oncol; 1995 Mar 01; 56(3):425-9. PubMed ID: 7705679 [Abstract] [Full Text] [Related]
30. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Rüschoff J, Bittinger A, Neumann K, Schmitz-Moormann P. Pathol Res Pract; 1990 Feb 01; 186(1):85-91. PubMed ID: 1690415 [Abstract] [Full Text] [Related]
31. Nucleolar organizer regions in prostatic adenocarcinomas. Comparison with flow cytometric analysis, tumor grade, stage and serum prostate-specific antigen levels. Alivizatos G, Pavlaki K, Giannopoulos A, Mitropoulos D, Tsega A, Deliveliotis C, Dimopoulos C. Eur Urol; 1992 Feb 01; 21(2):141-5. PubMed ID: 1379922 [Abstract] [Full Text] [Related]
32. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues. Ofner D, Bankfalvi A, Riehemann K, Bier B, Böcker W, Schmid KW. Mod Pathol; 1994 Dec 01; 7(9):946-50. PubMed ID: 7892164 [Abstract] [Full Text] [Related]
33. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma]. Lu XL, Yi WM, Wang LF. Ai Zheng; 2003 Jan 01; 22(1):62-5. PubMed ID: 12561439 [Abstract] [Full Text] [Related]
34. Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: prognostic value. Ferreres JC, Figols J, Val-Bernal JF, Cardesa A, Cruz Sánchez FF. Histol Histopathol; 1996 Jan 01; 11(1):35-9. PubMed ID: 8720446 [Abstract] [Full Text] [Related]
35. AgNOR counts have no prognostic value in breast cancer. Toikkanen S, Joensuu H. J Pathol; 1993 Feb 01; 169(2):251-4. PubMed ID: 8445490 [Abstract] [Full Text] [Related]
36. [Correlationship between cellular DNA and AgNOR protein content in the developing course of colorectal adenocarcinoma]. Qu HT, Xie Y, Chen XL. Zhonghua Zhong Liu Za Zhi; 1994 May 01; 16(3):192-5. PubMed ID: 7956697 [Abstract] [Full Text] [Related]
37. Prognostic significance of DNA cytometry in combination with AgNOR investigation. Coric M, Ladika-Davidovic B, Bumber Z, Danic D, Vuletic LB, Seiwerth S. Acta Otolaryngol; 2007 Dec 01; 127(12):1332-7. PubMed ID: 17851903 [Abstract] [Full Text] [Related]
38. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification. Trerè D, Migaldi M, Trentini GP. Anal Cell Pathol; 1995 Jan 01; 8(1):57-65. PubMed ID: 7734412 [Abstract] [Full Text] [Related]
39. Nucleolar organizer regions as a prognostic factor in surgically treated lung cancer patients. Lee YC, Chang DB, Lee JM, Luh SP, Kuo SH, Chang YL, Lee CJ. Thorac Cardiovasc Surg; 1996 Aug 01; 44(4):204-7. PubMed ID: 8896164 [Abstract] [Full Text] [Related]
40. AgNOR pattern and PCNA analysis in fine needle biopsies of liver cell carcinoma. Valenca JT, Escanhoel CA, Metze K. Neoplasma; 2001 Aug 01; 48(5):370-3. PubMed ID: 11845981 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]